Potentiation of human polymorphonuclear leukocyte phagocytosis and intracellular bactericidal activity by amoxycillin/clavulanic acid

Drugs under Experimental and Clinical Research

Volumn 22, Issue 1, 1996, Pages 9-15

  Cuffini, A M ^a,c   De Renzi, G ^a   Tullio, V ^a   Paizis, G ^b   Carlone, N A ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b SmithKline Beecham SpA   (Italy)

^c Istituto di Microbiologia   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE INHIBITOR;

ARTICLE; BACTERICIDAL ACTIVITY; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG POTENTIATION; HUMAN; HUMAN CELL; KLEBSIELLA PNEUMONIAE; NEUTROPHIL; PHAGOCYTOSIS; POLYMORPHONUCLEAR CELL; STAPHYLOCOCCUS AUREUS;

AMOXICILLIN; ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; CLAVULANIC ACID; CLAVULANIC ACIDS; DRUG INTERACTIONS; ENZYME INHIBITORS; HUMANS; KLEBSIELLA PNEUMONIAE; NEUTROPHILS; PENICILLINS; PHAGOCYTOSIS; STAPHYLOCOCCUS AUREUS;

EID: 0029742636     PISSN: 03786501     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Silver L.L., Bostian K.A. Discovery and development of new antibiotics: the problem of antibiotic resistance. Antimicrob. Agents Chemother., 37, 377, 1993.
2. Bush K. β-lactamase inhibitors from laboratory to clinic. Clin. Microbiol. Rev., 1, 109, 1988.
3. Carlone N.A., Cuffini A.M., Ferrero M., Tullio V., Avetta G. Cellular uptake and intracellular bactericidal activity of teicoplanin in human macrophages. J. Antimicrob. Chemother., 23, 849, 1989.
4. Cuffini A.M., Tullio V., Allocco A., Fazari S., Giachino F., Carlone N.A. Enhanced Slaphylococcus aureus susceptibility to immunodefences induced by subinhibitory and bactericidal concentration of imipenem. J. Antimicrob. Chemother., 31, 559, 1993.
5. Catherall E.J., Gillon V., Hurn S., Irwin R., Mizen L. Efficacy of ticarcillin-clavulanic acid for treatment of experimental Slaphylococcus aureus endocarditis in rats. Antimicrob Agents Chemother , 36, 458, 1992.
6. Krieger O., Bernhart M., Plobowich R., Nemec H., Lutz D. Timentin in combination with tobramycin as empirical therapy in febrile neutropenic patients with haematological malignancies. J. Antimicrob. Chemother., 17 (Suppl. C), 211. 1986.
7. Masson J.M., Kazmierczak A., Labia R. Interactions of clavulanic acid and sulbactam with penicillin-binding proteins. Drugs Exptl. Clin Res., IX, 513, 1983.
8. Wise R., Andrews J.M., Bedford K.A. In vitro study of clavulanic acid in combination with penicillin, amoxicillin and carbenicillin Antimicrob. Agents Chemother., 13, 389, 1978.
9. Cooper C.E., Slocombe B., White A.R., Effect of low concentrations of clavulanic acid on the in-vitro activity of amoxycilin against β-lactamase-producing Branhamella catarrhalis and Haemophilus influenzae. J. Antimicrob. Chemother. 26, 371, 1990.
10. Muratani T., Yokola E., Nakame T., Inoue E., Mitsuhashi S. In vitro evaluation of the four β-lactamase inhibitors: BRL42715, clavulanic acid, sulbactam, and tazobactam. J. Antimicrob. Chemother., 32, 421, 1993.
11. Barry A.L., Pfaller M.A., Fuchs P.C. The antibacterial activity of co-amoxiclav. J. Antimicrob. Chemother., 31, 612, 1993.
12. Coleman K, et al. Bacterial resistance mechanisms as therapeutic targets. J. Antimicrob. Chemother., 33, 1091, 1994.
13. Van den Broek P.J. Antimicrobial drugs, microorganisms and phagocytes. Rev. Infect. Dis., 11, 213, 1989.
14. Miler I., Borte M., Hejrlar M., Braun W. The effect of antibiotics on the function of the phagocytic system. Pediatr und Grenzgebiete, 19, 377, 1990.
15. Labro M.T., El Benna J., Abdelghaffar H. Modulation of human polymorphonuclear neutrophil function by macrolides: preliminary data concerning dirithromycin. J. Antimicrob. Chemother., 35, 1291, 1993.
16. Carlone N.A., Cuffini A.M., Tullio V., Cavallo G. Interactions of antibiotics with phagocytes in vitro. J. Chemother., 3 (Suppl 1), 98, 1991.
17. Carlone N.A., Cuffini A.M., Tullio V., Cavallo G. Carbapenems and potential immunomodulating properties. In: Masihi N. ed. "Immunotherapy of Infections". Marcel Dekker Inc. New York, 1994, pp 167-176.
18. Cuffini A.M., Carlone N.A., Tullio V., Cavallo G. Cell wall inhibitors and bacterial susceptibility to phagocytosis. In: Faist E., Meakins J.L., Schildberg F.W. eds. "Host defences dysfunction in trauma, shock and sepsis". Springer-Verlag, Berlin, 1993, pp. 979-985
19. Gemmel C.G. Antibiotics and neutrophil function: potential immunomodulating activities. J. Antimicrob. Chemother., 31 (Suppl. B), 23, 1993.
20. Schifferli D.M., Beachey E.H. Bacterial adhesion: modulation by antibiotics with primary targets other than protein synthesis. Anlimicrob Agents Chemother., 32, 1609, 1988.